cryptococcuspneumoniatreatment

由JRPerfect著作·2010·被引用3040次—Forcryptococcalpneumonia,usefluconazole(6–12mg/kgperdayorally)for6–12months(B-II).Cryptococcosisinaresource-limitedhealthcareenvironment.76.,2021年5月11日—InitialtherapyshouldbeamphotericinB(0.7-1mg/kg/day)aloneorincombinationwithflucytosine(100mg/kg/dayin4divideddoses).,,由GMCox著作·被引用10次—-Antifungaltherapy·-Surgery.,由MSSaag著作·2000·被引用1462次—Therap...

Clinical Practice Guidelines for the Management of ...

由 JR Perfect 著作 · 2010 · 被引用 3040 次 — For cryptococcal pneumonia, use fluconazole (6–12 mg/kg per day orally) for 6–12 months (B-II). Cryptococcosis in a resource-limited health care environment. 76.

Cryptococcosis Treatment & Management

2021年5月11日 — Initial therapy should be amphotericin B (0.7-1 mg/kg/day) alone or in combination with flucytosine (100 mg/kg/day in 4 divided doses).

Cryptococcus neoformans infection outside the central ...

由 GM Cox 著作 · 被引用 10 次 — - Antifungal therapy · - Surgery.

Practice Guidelines for the Management of Cryptococcal ...

由 MS Saag 著作 · 2000 · 被引用 1462 次 — Therapy with amphotericin B (0.7–1 mg/kg/d) for 2 weeks, followed by 8–10 weeks of fluconazole (400–800 mg/d), is followed with 6–12 months of suppressive ...

Pulmonary Cryptococcosis in the Immunocompetent ...

由 JF Fisher 著作 · 2016 · 被引用 54 次 — Clinical guidelines recommend oral fluconazole for patients with mild to moderate symptoms and amphotericin B plus flucytosine followed by ...

Pulmonary cryptococcosis

由 F Setianingrum 著作 · 2019 · 被引用 205 次 — The first line of treatment for pulmonary cryptococcosis is fluconazole, or amphotericin B and flucytosine for those with central nervous system ...

Treatment for C. neoformans Infection

People who have C. neoformans infection need to take prescription antifungal medication for at least 6 months, often longer. The type of treatment usually ...

Treatment outcomes of pulmonary cryptococcosis

由 H Li 著作 · 2022 · 被引用 1 次 — Guidelines recommend administering fluconazole (400 mg per day orally) for 6–12 months to patients with mild-to-moderate symptoms, while the ...